Rpl6l, a member of the ribosomal protein family, plays a crucial role in the intricate machinery of protein synthesis. Its involvement in ribosomal biogenesis positions it as a key contributor to cellular homeostasis and function. Activation of Rpl6l involves a complex interplay of signaling pathways influenced by various chemical modulators. These modulators directly or indirectly impact protein synthesis, triggering compensatory mechanisms that result in the up-regulation of Rpl6l levels within the ribosomes. The primary function of Rpl6l revolves around its role in ribosomal biogenesis and protein synthesis. It directly contributes to the structural integrity of the ribosome, ensuring efficient translation of genetic information into functional proteins. The activation of Rpl6l is intricately linked to the modulation of ribosomal protein synthesis, a process governed by diverse chemical regulators. Compounds such as rapamycin, cycloheximide, and puromycin directly activate Rpl6l by influencing protein synthesis, inducing compensatory up-regulation of ribosomal proteins, including Rpl6l. Additionally, mTOR inhibitors like Torin 1 and Torin 2 further highlight the significance of mTOR signaling in Rpl6l activation, emphasizing the central role of this ribosomal protein in cellular protein synthesis machinery.
In conclusion, the activation of Rpl6l is tightly regulated by the intricate balance of protein synthesis pathways. The diverse array of chemical modulators showcases the adaptability of Rpl6l to various cellular contexts, positioning it as a central player in the dynamic orchestration of ribosomal biogenesis and protein synthesis. The detailed understanding of Rpl6l activation mechanisms provides insights into the fundamental processes governing cellular function and lays the groundwork for further exploration of its role in maintaining cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin activates Rpl6l by inhibiting mTOR, triggering downstream signaling that up-regulates ribosomal protein synthesis. This directly enhances Rpl6l levels in ribosomes. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide directly activates Rpl6l by inhibiting protein synthesis, leading to a compensatory up-regulation of ribosomal proteins, including Rpl6l. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin dihydrochloride activates Rpl6l by inducing premature termination of protein synthesis, triggering ribosomal biogenesis and up-regulating Rpl6l levels. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Torin 1, an mTOR inhibitor, activates Rpl6l by down-regulating mTOR signaling, leading to increased ribosomal protein synthesis and elevated Rpl6l levels. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates Rpl6l by inhibiting protein synthesis, inducing a compensatory increase in ribosomal protein production, including Rpl6l. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
L-Leucine activates Rpl6l by promoting mTORC1 activation, enhancing ribosomal protein synthesis and increasing Rpl6l levels in ribosomes. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine activates Rpl6l by inhibiting protein synthesis, inducing a compensatory up-regulation of ribosomal proteins, including Rpl6l. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580, a p38 MAPK inhibitor, indirectly activates Rpl6l by modulating stress response pathways, influencing ribosomal protein synthesis and Rpl6l expression. | ||||||
Harringtonin | 26833-85-2 | sc-204771 sc-204771A sc-204771B sc-204771C sc-204771D | 5 mg 10 mg 25 mg 50 mg 100 mg | $250.00 $367.00 $548.00 $730.00 $980.00 | 30 | |
Harringtonin activates Rpl6l by inhibiting protein synthesis, inducing a compensatory up-regulation of ribosomal proteins, including Rpl6l. | ||||||
eIF4E/eIF4G Interaction Inhibitor, 4EGI-1 | 315706-13-9 | sc-202597 | 10 mg | $265.00 | 14 | |
4EGI-1, an eIF4E/eIF4G interaction inhibitor, directly activates Rpl6l by modulating translation initiation, influencing ribosomal protein synthesis and up-regulating Rpl6l. | ||||||